Biotronik adds new Reocor external pacemaker to its product portfolio

214

Biotronik has announced the European launch after receiving CE mark approval for its new Reocor external pacemakers, available in two models for dual and single chamber pacing therapy.

The new Reocor has an intuitive design for simplified usage and extended longevity that increases reliability and reduces costs over time. Simplified usage is achieved by the function dials displaying selectable parameter values and visualising programmed settings at a glance. Thus, easy handling is guaranteed without any specific training requirements. Extended battery service times of up to 25 days for permanent pacing therapy, supplemented with a backup power supply during battery replacement, ensure patient safety and longer continuous usage in daily practice. Reocor has also been enhanced to accommodate high pacing outputs and high pacing rates being especially important for pediatric care. Therefore Reocor effectively delivers individual solutions for a broad range of patients.

(Visited 48 times, 1 visits today)